Pursuant to the letter of intent, it is proposed that Bio-Matrix will perform human DNA genetic testing for biomarkers that may play important roles in disease development. Vibragene anticipates sending 100,000 specimens to Bio-Matrix for testing during the next 12 months. Additionally, Bio-Matrix will supply DNA testing kits to Vibragene for the collection of DNA specimens.
Completion of the proposed agreement is subject to a number of conditions, including but not limited to, the establishment of pricing acceptable to the parties.